3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-10-21 11:56 UTC
Adj EPS $1.42, Est. $1.42 Net Sales $13.01B, Est. $13B Comparable Sales +7% Sees Q4 Adj EPS $1.62—$1.67 Reaffirms FY EPS Guidance Plans to Separate Global Nutrition Business Into Public Company by End-2027 Daniel Salvadori to Become CEO of New Nutrition Company Separation Through Tax-Free Distribution to Shareholders S
News 2026-10-21 11:43 UTC
Abbott plans to separate its global Nutrition business, with approximately $8.5 billion in sales, into an independent public company through a share distribution to Abbott shareholders. The plan is subject to approvals.
News 2026-10-21 11:28 UTC
Abbott Laboratories said it plans to separate its nutrition business into an independent, publicly traded company.